Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

Clinical trial NCT00002572 · COMPLETED

Trial details

NCT number: NCT00002572
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1994-11-01
Primary completion: 1999-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.